Delaware County biopharm firm raises $110M, expects funding round to swell to $145M


The company is working to bring drugs approved in China to the United States and Europe.

Previous Excela Health, Butler Health System officially merged
Next With stock up 350%, Madrigal secures more than $300M to advance NASH drug candidate